Ventech Backs Covagen
Covagen AG, a Zurich-based developer of a novel class of protein therapeutics, has secured an undisclosed amount of seed funding from Ventech.
1 December 2009•3 mins read
Covagen AG, a Zurich-based developer of a novel class of protein therapeutics, has secured an undisclosed amount of seed funding from Ventech.
